"Concise industry news from the US pharmaceutical industry..."
New Account

The Magazine

Issue 1

Issue 1 E-magazine
  • Previous Issues

Sponsors

Platinum Sponsors
Gold Sponsors
Silver Sponsors
Platinum Sponsors
Gold Sponsors
Silver Sponsors

Blog

Where our team of guest writers discuss what they think about the current NGP US Issues.

Peter Duncan
Director of Business Development

Can digital pathology save drug development?

Peter Duncan of Definiens discusses the potential of digital pathology.
07 Jul 2010
Manufacturing
2 of 3 Previous | Next
Manufacturing

Don?t drop the ball


Manufacturers are juggling a plethora of issues in order to stay at the top

No Comments

Risk and quality management ? a supplier?s perspective


In September 2004, the FDA issued a final report on its Pharmaceutical Manufacturing Initiative (PMI).

No Comments

The benefits of checkweighing


Looking at checkweighers that reassure operators of compliant production, product completeness and repeatable quality control.

No Comments

Continuing development


Looking at a product synonymous with innovation and quality in bioprocess equipment.

No Comments

RNA interference


RNA interference (RNAi) emerged on the scene in the late 1990s as a previously recognized but relatively uncharacterized process in plants, fungi, and invertebrates.

No Comments
2 of 3 Previous | Next